Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults

被引:18
作者
Sutherland, Nykole [1 ]
Espinel, Whitney [2 ]
Grotzke, Marissa [3 ]
Colonna, Sarah [2 ]
机构
[1] Intermt Healthcare, Dept Precis Genom, Salt Lake City, UT 84143 USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[3] Univ Utah, Dept Internal Med, Div Endocrinol Diabet & Metab, Salt, Jordan
关键词
adolescents; disparities; genetic counseling; risk assessment; underrepresented population; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; HEALTH; GENDER; WOMEN; ESTROGEN; SERIES; SEX;
D O I
10.1002/jgc4.1278
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Transgender (TG) individuals have higher rates of mortality associated with cancer diagnoses, in part due to avoidance of gender-assigned cancer screenings resulting in later stages at diagnosis. Knowledge about the risks of breast or gynecological cancer in TG and nonbinary (NB) persons receiving gender-affirming hormone therapy is limited. Even less information exists regarding the subset of individuals with genetic predisposition for these malignancies. We performed a retrospective literature review of studies from the last 15 years on breast cancer rates and identified risks in TG persons. An accumulating body of data on breast cancer incidence in TG persons suggests higher than previously believed rates of breast cancer in TG women compared with cisgender men and risk correlating with duration of hormone use. Few studies have examined other cancer risks in TG populations. To date, only three publications address the association with BRCA1/2 mutation presence and breast cancer incidence in TG persons. Meanwhile, there is growing awareness and social acceptance of TG/NB identities coupled with recognition of gender dysphoria at increasingly earlier ages. No information directly addressing cancer risk counseling in TG/NB adolescents and young adults with a family history of cancer or hereditary cancer syndrome exists. Whether the presence of a known genetic predisposition or strong family cancer history may affect cancer risk in these populations is unknown, leading to significant gaps in clinicians' ability to accurately and appropriately estimate cancer risks and counsel those with genetic predisposition on the risks/benefits associated with surgical options and the initiation, duration, and dosing of gender-affirming hormone therapies. A series of three cases illustrates the utility of cancer risk assessment and genetic testing in TG/NB adolescents and young adults, and the unique challenges and unanswered questions that are encountered in the process.
引用
收藏
页码:625 / 633
页数:9
相关论文
共 39 条
[1]  
Arbour L., 2003, Paediatr Child Health, V8, P42, DOI [10.1093/pch/8.1.42, DOI 10.1093/PCH/8.1.42]
[2]   Suicide risk in the UK trans population and the role of gender transition in decreasing suicidal ideation and suicide attempt [J].
Bailey, Louis ;
Ellis, Sonja J. ;
McNeil, Jay .
MENTAL HEALTH REVIEW JOURNAL, 2014, 19 (04) :209-+
[3]   Trans-inclusive genetic counseling services: Recommendations from members of the transgender and non-binary community [J].
Barnes, Heather ;
Morris, Emily ;
Austin, Jehannine .
JOURNAL OF GENETIC COUNSELING, 2020, 29 (03) :423-434
[4]  
Bennett Robin L, 2008, J Genet Couns, V17, P424, DOI 10.1007/s10897-008-9169-9
[5]  
Borry P, 2009, EUR J HUM GENET, V17, P711, DOI [10.1038/ejhg.2009.25, 10.1038/ejhg.2009.26]
[6]   Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents [J].
Botkin, Jeffrey R. ;
Belmont, John W. ;
Berg, Jonathan S. ;
Berkman, Benjamin E. ;
Bombard, Yvonne ;
Holm, Ingrid A. ;
Levy, Howard P. ;
Ormond, Kelly E. ;
Saal, Howard M. ;
Spinner, Nancy B. ;
Wilfond, Benjamin S. ;
McInerney, Joseph D. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2015, 97 (01) :6-21
[7]   Incidence of breast cancer in a cohort of 5,135 transgender veterans [J].
Brown, George R. ;
Jones, Kenneth T. .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (01) :191-198
[8]   Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials [J].
Chlebowski, Rowan T. ;
Rohan, Thomas E. ;
Manson, JoAnn E. ;
Aragaki, Aaron K. ;
Kaunitz, Andrew ;
Stefanick, Marcia L. ;
Simon, Michael S. ;
Johnson, Karen C. ;
Wactawski-Wende, Jean ;
O'Sullivan, Mary J. ;
Adams-Campbell, Lucile L. ;
Nassir, Rami ;
Lessin, Lawrence S. ;
Prentice, Ross L. .
JAMA ONCOLOGY, 2015, 1 (03) :296-305
[9]   Hormonal and Surgical Treatment in Trans-Women with BRCA1 Mutations: A Controversial Topic [J].
Colebunders, Britt ;
T'Sjoen, Guy ;
Weyers, Steven ;
Monstrey, Stan .
JOURNAL OF SEXUAL MEDICINE, 2014, 11 (10) :2496-2499
[10]   Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 [J].
Coleman, E. ;
Bockting, W. ;
Botzer, M. ;
Cohen-Kettenis, P. ;
DeCuypere, G. ;
Feldman, J. ;
Fraser, L. ;
Green, J. ;
Knudson, G. ;
Meyer, W. ;
Monstrey, S. ;
Adler, R. ;
Brown, G. ;
Devor, A. ;
Ehrbar, R. ;
Ettner, R. ;
Eyler, E. ;
Garofalo, R. ;
Karasic, D. ;
Lev, A. ;
Mayer, G. ;
Meyer-Bahlburg, H. ;
Hall, B. ;
Pfaefflin, F. ;
Rachlin, K. ;
Robinson, B. ;
Schechter, L. ;
Tangpricha, V. ;
van Trotsenburg, M. ;
Vitale, A. ;
Winter, S. ;
Whittle, S. ;
Wylie, K. ;
Zucker, K. .
INTERNATIONAL JOURNAL OF TRANSGENDERISM, 2012, 13 (04) :165-232